Yuyu Pharma Cash Flow | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Yuyu Pharma Inc.

Yuyu Pharma Inc. | Cash Flow

Fiscal year is January-December. All values KRW Millions.

2013

2014

2015

2016

2017

2018

Net Income before Extraordinaries

2,979

1,877

7,363

404

4,289

4,312

Depreciation, Depletion & Amortization

1,549

1,633

1,510

1,542

1,461

2,127

Other Funds

979

2,307

Funds from Operations

8,103

4,353

1,029

5,290

6,318

8,746

Changes in Working Capital

1,766

4,562

2,713

17,138

5,242

2,819

Net Operating Cash Flow

6,336

209

1,684

11,848

1,077

5,928

Capital Expenditures

1,032

1,374

638

2,216

4,534

Sale of Fixed Assets & Businesses

807

1,719

Purchase/Sale of Investments

517

3,235

2,761

1,441

288

Net Investing Cash Flow

1,542

3,374

2,494

3,652

2,810

Cash Dividends Paid - Total

718

953

1,071

1,202

1,274

Issuance/Reduction of Debt, Net

4,950

8,315

639

13,255

2,585

Net Financing Cash Flow

5,487

8,349

442

14,231

2,650

Net Change in Cash

693

4,766

3,744

1,285

907

Free Cash Flow

5,531

1,164

1,280

13,936

3,425

Other Sources

136

575

371

Change in Capital Stock

181

2,191

1,339

Exchange Rate Effect

Other Uses

150

147

293

About Yuyu Pharma

View Profile

Address	94 Bio valley 1-ro Jecheon NC 27159 Korea, Republic Of
Employees	-
Website	http://www.yuyu.co.kr
Updated	07/08/2019
Yuyu Pharma, Inc. engages in the manufacture and sale of pharmaceuticals. It operates through the Prescription and Non-prescription divisions. The Prescription division provides circulatory improvement agents, bone metabolism ameliorants, antihypertensive drugs, topical corticosteroids, antiplatelet agents, gout prepartions, angina pectoris drugs, osteoporosis drugs, antidiabetic agents, antibiotics, antiulcerants, varicose preparations, antitubercular agents, and hemorrhoidal.